Boston Scientific Corp

DnB Asset Management AS BSX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

374,557

Value ($000)

35,714

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	35,714	0.1%	374,557	12/31/2025
2025 Q3	11/12/2025	38,987	0.1%	399,330	9/30/2025
2025 Q2	8/12/2025	47,429	0.2%	441,574	6/30/2025
2025 Q1	5/15/2025	47,971	0.2%	475,528	3/31/2025
2024 Q4	2/12/2025	41,111	0.2%	460,272	12/31/2024
2024 Q3	11/12/2024	21,896	0.1%	261,287	9/30/2024
2024 Q2	7/5/2024	19,241	0.1%	249,853	6/30/2024
2024 Q1	4/12/2024	16,016	0.1%	233,846	3/31/2024
2023 Q4	1/4/2024	29,402	0.2%	508,592	12/31/2023
2023 Q3	10/13/2023	27,132	0.2%	513,856	9/30/2023
2023 Q2	7/10/2023	27,064	0.2%	500,356	6/30/2023
2023 Q1	4/20/2023	25,074	0.2%	501,178	3/31/2023
2022 Q4	1/12/2023	30,922	0.2%	668,292	12/31/2022
2022 Q3	10/11/2022	26,767	0.2%	691,108	9/30/2022
2022 Q2	7/8/2022	25,861	0.2%	693,877	6/30/2022
2022 Q1	4/8/2022	31,178	0.2%	703,950	3/31/2022
2021 Q4	1/12/2022	32,889	0.2%	774,218	12/31/2021
2021 Q3	10/15/2021	32,971	0.2%	759,873	9/30/2021
2021 Q2	7/6/2021	32,345	0.2%	756,436	6/30/2021
2021 Q1	4/15/2021	32,890	0.2%	850,966	3/31/2021
2020 Q4	1/19/2021	34,101	0.3%	948,558	12/31/2020
2020 Q3	10/14/2020	14,798	0.2%	387,284	9/30/2020
2020 Q2	7/8/2020	12,443	0.1%	354,399	6/30/2020
2020 Q1	4/17/2020	11,172	0.2%	342,381	3/31/2020
2019 Q4	1/13/2020	16,659	0.2%	368,396	12/31/2019
2014 Q2	7/7/2014	963	0.0%	75,450	6/30/2014
2013 Q4	1/27/2014	560	0.0%	46,550	12/31/2013